OpenURL Connection Search

Select item for more details and to access through your institution.

Disturbances of menstrual cycle after immunization against SARS‐CoV‐2 and their risk factors: Cross‐sectional clinical study.
Published in:
International Journal of Gynecology & Obstetrics, 2023, v. 163, n. 2, p. 445, doi. 10.1002/ijgo.15060
By:
- Lukac, Stefan;
- Hancke, Katharina;
- Janni, Wolfgang;
- Gruber, Tobias;
- Schmid, Marinus;
- El‐Taie, Ziad;
- Kersten, Maria;
- Friedl, Thomas Wolfram Paul;
- Dayan, Davut
Publication type:
Article
LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Published in:
Molecular Oncology, 2017, v. 11, n. 11, p. 1508, doi. 10.1002/1878-0261.12111
By:
- Trapp, Elisabeth Katharina;
- Majunke, Leonie;
- Zill, Beate;
- Sommer, Harald;
- Andergassen, Ulrich;
- Koch, Julian;
- Harbeck, Nadia;
- Mahner, Sven;
- Friedl, Thomas Wolfram Paul;
- Janni, Wolfgang;
- Rack, Brigitte;
- Alunni ‐ Fabbroni, Marianna
Publication type:
Article
Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project.
Published in:
2020
By:
- De Gregorio, Amelie;
- Nagel, Gabriele;
- Möller, Peter;
- Rempen, Andreas;
- Schlicht, Erik;
- Fritz, Steffen;
- Flock, Felix;
- Kühn, Thorsten;
- Thiel, Falk;
- Felberbaum, Ricardo;
- Ebner, Florian;
- De Gregorio, Nikolaus;
- Friedl, Thomas Wolfram Paul;
- Wiesmüller, Lisa;
- Kuhn, Peter;
- Schmitt, Margit;
- Janni, Wolfgang;
- Rothenbacher, Dietrich;
- Huober, Jens
Publication type:
journal article
Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors.
Published in:
Oncology, 2021, v. 99, n. 12, p. 780, doi. 10.1159/000517490
By:
- de Gregorio, Amelie;
- Friedl, Thomas Wolfram Paul;
- Hering, Eva;
- Widschwendter, Peter;
- de Gregorio, Nikolaus;
- Bekes, Inga;
- Janni, Wolfgang;
- Dayan, Davut;
- Huober, Jens Bodo
Publication type:
Article
Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB.
Published in:
Oncology, 2020, v. 98, n. 2, p. 91, doi. 10.1159/000503149
By:
- de Gregorio, Amelie;
- Widschwendter, Peter;
- Ebner, Florian;
- Friedl, Thomas Wolfram Paul;
- Huober, Jens;
- Janni, Wolfgang;
- de Gregorio, Nikolaus
Publication type:
Article

Found: 5

Disturbances of menstrual cycle after immunization against SARS‐CoV‐2 and their risk factors: Cross‐sectional clinical study.

LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.

Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project.

Ki67 as Proliferative Marker in Patients with Early Breast Cancer and Its Association with Clinicopathological Factors.

Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB.